Correspondence on acceptability of COVID-19 vaccination with bronchopulmonary dysplasia.

Dear Editor, we would like to share ideas on the publication "Acceptability of COVID-19 vaccination in Chinese children aged 3-7 years with bronchopulmonary dysplasia [1]." Wang et al. [1] investigated the status of COVID-19 vaccination with inactivated vaccines BBIBP-CorV and CoronaVac in Chinese children aged 3-7 years with bronchopulmonary dysplasia (BPD), as well as factors influencing vaccination and reasons for non-vaccination. Wang et al. concluded that the COVID-19 vaccination rate in BPD children aged 3-7 years in China needs to be increased [1]. Wang et al. concluded that ongoing efforts are needed to monitor post-vaccination adverse reactions in children with BPD and to make vaccination more convenient and accessible [1]. This article is protected by copyright. All rights reserved.